Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Marmara Pharmaceutical Journal
2017 , Vol 21 , Issue 1
Synthesis and Evaluation of New Imidazo[2,1-b]Thiazoles as AntituberculosisAgents
1Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, 34116 Istanbul, Turkey
DOI :
10.12991/marupj.259887
New N"-(arylidene)-2-[6-(4-bromophenyl)imidazo[2,1-b]
thiazol-3-yl]acetohydrazides (3a-i) were synthesized by
reacting 2-[6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]
acetohydrazide with different aromatic aldehydes. The structures
of the title compounds were established by spectral data (IR,
1H NMR, 13C NMR) and elemental analyses. The synthesized
compounds were evaluated for in vitro antimycobacterial
activity against Mycobacterium tuberculosis H37Rv employing the BACTEC 460 radiometric system. The compounds exhibited
varying degrees of inhibition in the in vitro primary screening
that was conducted at a concentration of 6.25 mg/ml. Among
the synthesized compounds [6-(4-bromophenyl)imidazo[2,1-b]
thiazol-3-yl]acetic acid 2,4-dinitrobenzylidenehydrazide (3e)
was found to be the most active compound in vitro with MIC
of 6.25 mg/ml.
Keywords :
Imidazo[2,1-b]thiazole, hydrazone, antimycobacterial activity